131 related articles for article (PubMed ID: 11213833)
21. Allelotype of neuroblastoma.
Takita J; Hayashi Y; Kohno T; Shiseki M; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
Oncogene; 1995 Nov; 11(9):1829-34. PubMed ID: 7478611
[TBL] [Abstract][Full Text] [Related]
22. A candidate tumor suppressor locus for scirrhous gastric cancer at chromosome 18q 12.2.
Nishioka N; Yashiro M; Inoue T; Matsuoka T; Ohira M; Chung KH
Int J Oncol; 2001 Feb; 18(2):317-22. PubMed ID: 11172598
[TBL] [Abstract][Full Text] [Related]
23. Differences in genomic instability between intestinal- and diffuse-type gastric cancer.
Vauhkonen M; Vauhkonen H; Sajantila A; Sipponen P
Gastric Cancer; 2005; 8(4):238-44. PubMed ID: 16328598
[TBL] [Abstract][Full Text] [Related]
24. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.
Shiseki M; Kohno T; Nishikawa R; Sameshima Y; Mizoguchi H; Yokota J
Cancer Res; 1994 Nov; 54(21):5643-8. PubMed ID: 7923210
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity analysis of chromosomes 9, 10 and 17 in gliomas in families.
Watling CJ; van Meyel DJ; Ramsay DA; Macdonald DR; Cairncross JG
Can J Neurol Sci; 1995 Feb; 22(1):17-21. PubMed ID: 7750067
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas.
Lee JY; Finkelstein S; Hamilton RL; Rekha R; King JT; Omalu B
Neurosurgery; 2004 Nov; 55(5):1163-73. PubMed ID: 15509323
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
[TBL] [Abstract][Full Text] [Related]
28. Fractional allele loss indicates distinct genetic populations in the development of squamous cell carcinoma of the head and neck (SCCHN).
Nunn J; Scholes AG; Liloglou T; Nagini S; Jones AS; Vaughan ED; Gosney JR; Rogers S; Fear S; Field JK
Carcinogenesis; 1999 Dec; 20(12):2219-28. PubMed ID: 10590212
[TBL] [Abstract][Full Text] [Related]
29. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma.
Nishida N; Fukuda Y; Kokuryu H; Sadamoto T; Isowa G; Honda K; Yamaoka Y; Ikenaga M; Imura H; Ishizaki K
Int J Cancer; 1992 Jul; 51(6):862-8. PubMed ID: 1322376
[TBL] [Abstract][Full Text] [Related]
31. Clonal heterogeneity in sporadic melanomas as revealed by loss-of-heterozygosity analysis.
Takata M; Morita R; Takehara K
Int J Cancer; 2000 Feb; 85(4):492-7. PubMed ID: 10699920
[TBL] [Abstract][Full Text] [Related]
32. Allelic losses of 17p, 5q, and 18q loci in diploid and aneuploid populations of multiploid colorectal carcinomas.
Sugai T; Habano W; Nakamura S; Sato H; Uesugi N; Orii S; Itoh C; Katoh R
Hum Pathol; 2000 Aug; 31(8):925-30. PubMed ID: 10987252
[TBL] [Abstract][Full Text] [Related]
33. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
Brewster SF; Browne S; Brown KW
J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
[TBL] [Abstract][Full Text] [Related]
34. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity at 1p, 8p, 10p, 13q, and 17p in advanced urothelial cancer and lack of relation to chemotherapy response and outcome.
Sengeløv L; Christensen M; von der Maase HD; Horn T; Marcussen N; Kamby C; Orntoft T
Cancer Genet Cytogenet; 2000 Dec; 123(2):109-13. PubMed ID: 11156735
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables.
Koo SH; Jeong TE; Kang J; Kwon KC; Park JW; Noh SM
Cancer Genet Cytogenet; 2004 Aug; 153(1):26-31. PubMed ID: 15325090
[TBL] [Abstract][Full Text] [Related]
37. Three distinct regions of allelic deletion on chromosome 17 involved in sporadic gastric cancer.
Yu J; Zhou H; Jin Y; Bai J; Yu Y; Geng J; Qi J; Fu S
Hepatogastroenterology; 2008; 55(85):1487-91. PubMed ID: 18795719
[TBL] [Abstract][Full Text] [Related]
38. Evidence for loss of heterozygosity (LOH) at chromosomes 9p and 17p in oral granular cell tumors: a pilot study.
Gomes CC; Fonseca-Silva T; Gomez RS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):249-53. PubMed ID: 23312918
[TBL] [Abstract][Full Text] [Related]
39. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity analysis on chromosome 5p defines 5p13-12 as the critical region involved in tumor progression of bladder carcinomas.
Böhm M; Kleine-Besten R; Wieland I
Int J Cancer; 2000 Mar; 89(2):194-7. PubMed ID: 10754499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
